Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-01 Sale |
2023-03-02 9:25 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,201 | $33.5 | $107,234 | 49,390 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 9:38 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,201 | $34.6 | $110,755 | 105,111 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-23 5:35 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
1,000 | $31 | $31,000 | 57,877 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 8:06 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,701 | $27.16 | $100,525 | 58,877 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 4:55 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
11,000 | $27.07 | $297,798 | 31,694 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award |
2023-03-03 4:32 pm |
2024-03-01 2033-02-28 |
Revance Therapeutics Inc. | RVNC | Coric Vlad Director |
13,771 | $0 | 13,771 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,766 | $33.21 | 93,046 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-16 8:28 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
2,085 | $33.21 | 52,591 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:38 pm |
N/A 2033-01-30 |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
50,435 | $0 | 105,111 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:37 pm |
N/A 2033-01-30 |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
43,774 | $0 | 43,774 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:37 pm |
N/A 2033-01-30 |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
43,255 | $0 | 43,255 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-03 4:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
645 | $12.18 | 62,578 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-03 4:28 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
605 | $12.18 | 95,812 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-03 4:28 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
605 | $12.18 | 829,005 (Direct) |
View |
| 2022-12-15 Tax Withholding |
2022-12-16 4:12 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
1,557 | $21.5 | 61,933 (Direct) |
View |
| 2022-12-15 Tax Withholding |
2022-12-16 4:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,916 | $21.5 | 95,207 (Direct) |
View |
| 2022-10-13 Tax Withholding |
2022-10-14 7:02 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
49,274 | $26.97 | 828,400 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
1,000 | $11.75 | 877,674 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,000 | $11.75 | 98,123 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
965 | $11.75 | 63,490 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:17 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:16 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:14 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:13 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Vickers Philip J. Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:11 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:10 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award(A) |
2022-05-13 6:08 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
10,756 | $0 | 10,756 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:20 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Vickers Philip J. Director |
17,402 | $0 | 41,065 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:19 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
17,402 | $0 | 36,415 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:19 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
17,402 | $0 | 24,370 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:18 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
17,402 | $0 | 37,915 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:18 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
17,402 | $0 | 36,415 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:18 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
17,402 | $0 | 44,315 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:17 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
17,402 | $0 | 24,484 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President of R&D |
2,607 | $15.79 | 120,708 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:54 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J Chief Executive Officer |
3,304 | $15.79 | 876,674 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:52 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
5,110 | $15.79 | 42,694 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:50 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Rankin Aubrey Director |
1,372 | $15.79 | 570,004 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:48 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin Chief Financial Officer |
2,607 | $15.79 | 62,525 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:43 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,835 | $15.79 | 97,123 (Direct) |
View |